Evidence map›Paper›PMID 39361717›Full record

ArticlePLoS genetics2024

The middle domain of Hsp104 can ensure substrates are functional after processing.

Hannah E Buchholz, Jane E Dorweiler, Sam Guereca, Brett T Wisniewski, James Shorter, Anita L Manogaran

Abstract read
In one paragraph

Article in PLoS genetics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hannah E BuchholzDepartment of Biological Sciences, Marquette University, Milwaukee, Wisconsin, United States of America.ORCID https://orcid.org/0000-0003-3040-1596
Jane E DorweilerDepartment of Biological Sciences, Marquette University, Milwaukee, Wisconsin, United States of America.
Sam GuerecaDepartment of Biological Sciences, Marquette University, Milwaukee, Wisconsin, United States of America.
Brett T WisniewskiDepartment of Biological Sciences, Marquette University, Milwaukee, Wisconsin, United States of America.ORCID https://orcid.org/0000-0001-6157-1307
James ShorterDepartment of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.ORCID https://orcid.org/0000-0001-5269-8533
Anita L ManogaranDepartment of Biological Sciences, Marquette University, Milwaukee, Wisconsin, United States of America.ORCID https://orcid.org/0000-0003-0844-1479

Funding

Defining the mechanistic basis of a prion disaggregaseR01GM099836 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI SHORTER, JAMES · 2013 to 2024
$3.9M
NIGMS NIH HHS R01 GM099836
6 · The paper itself

Abstract

Molecular chaperones play a central role in protein disaggregation. However, the molecular determinants that regulate this process are poorly understood. Hsp104 is an AAA+ ATPase that disassembles stress granules and amyloids in yeast through collaboration with Hsp70 and Hsp40. In vitro studies show that Hsp104 processes different types of protein aggregates by partially translocating or threading polypeptides through the central pore of the hexamer. However, it is unclear how Hsp104 processing influences client protein function in vivo. The middle domain (MD) of Hsp104 regulates ATPase activity and interactions with Hsp70. Here, we tested how MD variants, Hsp104A503S and Hsp104A503V, process different protein aggregates. We establish that engineered MD variants fail to resolve stress granules but retain prion fragmentation activity required for prion propagation. Using the Sup35 prion protein, our in vitro and in vivo data indicate that the MD variants can disassemble Sup35 aggregates, but the disaggregated protein has reduced GTPase and translation termination activity. These results suggest that the middle domain can play a role in sensing certain substrates and plays an essential role in ensuring the processed protein is functional.

Indexed as

Heat-Shock ProteinsSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsAdenosine TriphosphatasesAmyloidHSP40 Heat-Shock ProteinsHSP70 Heat-Shock ProteinsMolecular ChaperonesPeptide Termination FactorsPrionsProtein AggregatesProtein DomainsAdenosine TriphosphatasesAmyloidHeat-Shock ProteinsHsP104 protein, S cerevisiaeHSP40 Heat-Shock ProteinsHSP70 Heat-Shock ProteinsMolecular ChaperonesPeptide Termination FactorsPrionsProtein AggregatesSaccharomyces cerevisiae ProteinsSUP35 protein, S cerevisiae

Identifiers

PMID39361717
PMCPMC11478891

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.